These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 4622788

  • 1. Profile of insulin release due to intrapancreatic glyburide infusion.
    Colwell AR, Zuckerman L.
    Diabetes; 1972 Apr; 21(4):209-15. PubMed ID: 4622788
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide.
    Artini D, Abbiati R, Orsini G, Parenti MA, Bloch K, Daturi S, Mandelli V.
    Diabetologia; 1973 Sep; ():311-6. PubMed ID: 4204091
    [No Abstract] [Full Text] [Related]

  • 3. Insulinotropic action of a new sulfonylurea: gliclazide.
    Malaisse WJ, Leclercq-Meyer V.
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):310-4. PubMed ID: 4626523
    [No Abstract] [Full Text] [Related]

  • 4. Unaltered glucagon secretion after seven days of sulphonylurea administration in normal subjects.
    Marco J, Valverde I.
    Diabetologia; 1973 Sep; ():317-9. PubMed ID: 4204092
    [No Abstract] [Full Text] [Related]

  • 5. [Studies on dose-response relationship of various sulfonylurea derivatives of the old and the new generation with further hints to extrapancreatic mechanisms of decreasing blood sugar].
    Haupt E, Köberich W, Cordes U, Beyer J, Schöffling K.
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2203. PubMed ID: 4198968
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Recent findings in the use of 1st and 2nd generation hypoglycemic sulfonamides].
    Schöffling K, Haupt E, Köberich W, Beyer J.
    Klin Wochenschr; 1973 Jan 15; 51(2):68-77. PubMed ID: 4631325
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Progress in therapy for diabetes mellitus--insulin-secretion inducing oral hypoglycemic agents].
    Nagashima K, Inagaki N.
    Nihon Naika Gakkai Zasshi; 2009 Apr 10; 98(4):737-41. PubMed ID: 19472523
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
    Haupt E, Beyer J, Schöffling K.
    Dtsch Med Wochenschr; 1974 Mar 01; 99(9):385-8. PubMed ID: 4208186
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide. II. Repeated administration in combination with glucose.
    Haupt E, Köberich W, Beyer J, Schöffling K.
    Diabetologia; 1971 Dec 01; 7(6):455-60. PubMed ID: 5004179
    [No Abstract] [Full Text] [Related]

  • 16. [Mechanism of action of gliquidone (author's transl)].
    Zilker T, Ermler R, Henderkott U, Bottermann P.
    Dtsch Med Wochenschr; 1975 Aug 29; 100(35):1733-4, 1739-41. PubMed ID: 808405
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.